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In 1995 Interbull undertook its first 
international MACE genetic evaluation in 
Holsteins across 9 countries. The concept of 
such a service began as far back as 1975 but its 
urgency intensified with increased 
international trade of frozen dairy bull semen.  
The objective of Interbull was to utilize all 
available data on individual sires within each 
member country to generate more accurate 
predictions of genetic merit on the individual 
scales of the different countries.  
 
Whilst there was sharing of national proofs 
before the introduction of MACE, the handicap 
was that it involved a lot of extra work, 
including the exchange of relevant files and 
development of conversion equations between 
participating countries. Despite this extra work 
requirement, there were still major concerns 
when MACE was first introduced, primarily 
around the accuracy of these new proofs and 
the more direct involvement of Interbull in the 
process. Today, these concerns have all been 
allayed, with 30 countries now participating in 
the service and each considering MACE 
evaluations as the standard tool for selecting 
bulls on both a within and an across country 
basis. Compared to the previous conversion-
based approach, MACE is better statistically, it 
saves time and money for individual members 
and it guarantees the same method and rules 
for all participating countries. 
 
Today there is some concern that a new 
type of data, invaluable in the generation of 
genomic breeding values, should be shared 
between participating countries and/or at 
Interbull. The consequence is that many 
countries are now participating in bi-lateral and 
multi-lateral sharing arrangements, with 
consequential effects on time, effort and 
money. Clearly, given our collective 
experiences with MACE and the benefits of 
open collaboration in this area there is much 
scope for more discussion on this subject. 
 
The objective of this paper is therefore to 
review the current state of the art in national 
genomic evaluations and international 
cooperation in genomic evaluations, and to put 
forward some points for discussion. The paper 
will be structured on the five “W”s; who, what, 




Who is collaborating? 
 
Although still early days in the implementation 
of genomic selection, the results emanating 
from the countries that implemented genomic 
selection indicate that genomic selection, or 
some derivative of such, will be the new 
system for identifying genetically elite animals. 
Therefore, any country with a national genetic 
evaluation system and a mission statement of 
providing the most accurate genetic 
evaluations possible to its stakeholders should 
be interested in cooperating on international 
genomic evaluation.  
 
Some adversaries to genomic cooperation 
may think that cooperation in genomics is only 
beneficial to smaller countries that import 
semen. However, access to the best software 
and training population to undertake genomic 





evaluations is not only vital for importing 
countries but is also crucial for the accurate 
evaluation of bulls being marketed by 
exporting countries.  
 
In December 2008 the Interbull Center 
undertook a survey on genomic selection 
across all member organisations. All 31 
organisations answered. At that time, 5 groups 
of countries were co-operating in genomic 
evaluations: 1) Denmark-Finland-Sweden, 2) 
Canada and the USA, 3) The Netherlands and 
New Zealand, 4) Ireland and New Zealand, 
and 5) Austria and Germany. An additional 8 
other countries indicated that they would 
probably collaborate in the future, totalling 17 
countries in all. Since this survey, it is 
interesting to note that some of the countries 
that did not indicate, at that time, that they 
were willing to cooperate are in fact now 
swapping bull genotypes. Therefore, it is clear 
that the appetite for cooperating in genomic 
selection breeding programs is present and 
appears to be increasing. It is obvious that all 
countries should be interested in collaboration 
on genomic evaluations to ensure each country 
has access to the best expertise and resources 
available and ultimately the best genetics. 
 
 
What are they collaborating on? 
 
Collaboration comes under many guises: 1) 
expertise and knowledge, 2) software, 3) 
phenotypes, and 4) genotypes. All 4 types of 
collaboration are underway in dairy cattle 
breeding. Expertise and knowledge are being 
shared at Interbull workshops and other 
international conferences. Software is being 
shared, for example through 
genomicseletion.net 
(http:///www.genomicselection.net ; Coffey 
and Mrode, 2009). Phenotypes, in the form of 
national proofs are being shared through 
Interbull, although only on traits for which 
international genetic evaluations are 
undertaken. A more recent development has 
seen the sharing of sire-dam pedigree files, as 
part of each country’s efforts to maximise the 
accuracy of MACE evaluations. Genotypes are 
being shared by some countries through 
bilateral agreements, or through consortia such 
as the North American Consortium, 
EuroGenomics or Intergenomics; expertise and 
computer code is also shared through these 
agreements.  
 
The question is what ideally should be 
swapped? When asked in the Interbull survey 
on what data each country would be willing to 
supply to Interbull, only Ireland was willing to 
supply any relevant data although many 
countries did not appear to respond to this 
question, probably because it was not already 
defined as to who would own the genotype 
information in those countries.  Given the 
likely change in perception of genomic 
selection in the past 18 month, would a re-run 
of the survey obtain a different set of results? 
 
Using the simulation study of VanRaden 
(2009) based on 8,193 Brown Swiss bulls from 
9 countries, Sullivan and VanRaden (2009) 
evaluated alternative methods of international 
genomic evaluations. Although the differences 
were relatively small, in the majority of 
countries multi-trait genomic evaluations 
achieved higher accuracy than G-MACE at 
that time. However, the G-MACE 
methodology has since been refined (Sullivan 
and VanRaden, 2010). Nonetheless, 
theoretically at least, sharing of all genotypic 
and phenotypic data should be optimal when 
deriving international genomic evaluations.  
 
When did the collaborations commence? 
 
In early 2008, the US and Canada joined forces 
to create a large training population for 
Holstein-Friesians. Clubware, the collaboration 
on software development began in October 
2008. In December 2008, Ireland and New 
Zealand shared 3,000 genotypes of Holstein-
Friesian bulls. In early 2009, discussions 
between CRV, DHV/VIT, UNCEIA and 
VikingGenetics began on the development of 
an agreement which was later called 
EuroGenomics (David et al., 2010); exchange 
of genotypes began in the fall of 2009. 
Intergenomics, an international collaboration 
on genomic selection for Brown Swiss began 
in 2009. 
 
March 2009 saw the beginning of an 
initiative to generate a file that contained all 
the Holstein-Friesian bulls genotyped in the 
world with the Illumina Bovine50 Beadchip, as 





well as those with DNA available for 
genotyping. This was an attempt by a number 
of countries to avoid further duplication in 
genotyping and to facilitate the process of 
sharing genotypes across countries, for those 
countries interested in pursuing this objective. 
This file to-date contains 36,898 bulls from 13 
different countries (US and Canada are treated 
as one “country”), and will be reported on at 
the Interbull business meeting in Riga by Berry 
et al.  
 
Where is the collaboration happening? 
 
To-date most collaboration has been 
undertaken through bilateral agreements 
between national evaluations centers, 
herdbooks, and AI companies as well as 
through multi-lateral agreements between a 
small number of countries. In the December 
2008 survey of member countries undertaken 
by Interbull, a question was asked on the 
expected role of Interbull in genomic 
evaluations. Of the 18 countries that made 
suggestions, 8 countries mentioned that 
Interbull should either store the genotypes or 
facilitate/coordinate the exchange of genotypes. 
Three countries, Australia, Ireland and New 
Zealand suggested that Interbull should store 
all genotypes presumably to undertake 
international genomic evaluations using all 
available genotypes.  
 
Why is the collaboration happening? 
 
There are many reasons as to why 
collaboration in sharing of genotypes is 
underway. These include: 
Increasing the reference population. The 
motivation for international genomic 
evaluations now is identical to the motivation 
for the establishment of Interbull over 35 years 
ago. The most accurate proofs, be they genetic 
or genomic, are fundamental to success for 
both importing and exporting countries alike. 
Between Ireland, North America, Switzerland, 
Poland, Israel, Italy, Japan, New Zealand and 
Australia, 30,643 Holstein bulls have been 
genotyped of which 20,739 have a MACE 
evaluation for milk production. Canada 
reported an increase in accuracy of 0.16 using 
a training population size of 9,300 genotypes 
with domestic (~2000 bulls) and MACE proofs 
(Muir et al., 2010). Using a very simplistic 
calculation, assuming the marginal benefit in 
accuracy of increasing the training population 
size from 9,300 to 20,739 is the same as from 
zero to 9,300 genotypes this equates to an 
overall increased accuracy of ~0.32 from using 
a training population size of 20,739 genotypes. 
VanRaden et al. (2009) suggested that 
reliability of genomic evaluations could 
increase to over 80% if the reference 
population was >40,000 proven bulls.  
 
Table 1. The benefit in reliability of DGVs of 
including genotyped bulls with MACE 
evaluations in the Irish national genomic 
evaluations. 
  Rel. 
Parent Average Only 0.302 
Genotypes + Domestic Proofs 0.418 
Genotypes + (Domestic & 
MACE proofs) 0.523 
 
Incorporating genotyped bulls with MACE 
evaluations into national genomic evaluations 
has been shown in many populations to 
increase the accuracy of selection (Muir et al., 
2010; Schrooten and van der Linde, 2010). 
Table 1 summarises the benefit of including 
genotyped bulls with MACE evaluations for 
milk protein yield over and above only 
including genotyped bulls with domestic 
evaluations in Ireland. The majority of 
genotypes used in genomic selection in Ireland 
have been attained through swapping with 
New Zealand, Switzerland, Poland, the UK, 
and Italy. In the most recent evaluation run 
(May 2010), there were 3,660 genotypes 
included in the training population for milk 
production and 4,561 genotypes included in 
the full run. It is prudent to note that some 70% 
of the training population in the Irish 
evaluation was obtained from bi-lateral sharing 
arrangements. 
Avoid repeated genotyping. Genotyping of 
animals is now relatively cheap and the 
technology platforms for genotyping are 
available to all. Therefore, there is little 
competitive advantage other than who has the 
most money. However, as previously alluded, 
money can be saved by sharing of information 
on animals genotyped and subsequent 





swapping of these genotypes. Between Ireland, 
Poland, Switzerland, Japan, Israel, Italy, 
Australia and New Zealand, 257 Holstein-
Friesian bulls have been genotyped more than 
once. Including the US and Canada the number 
of bulls genotyped more than once increases to 
522. Among these 522 bulls, 401 have been 
genotyped twice, 84 have been genotyped 
three times, 27 have been genotyped four times, 
8 bulls (Silky Gibson, Silky Cousteau, Bosside 
Ruben, Sandy Valley Forbidden, Roylane 
Jordan, Pursuit September Storm, Ricecrest 
Brett, and Sikkema-Star Air Magna) have been 
genotyped 5 times and 2 bulls (Jocko Besne 
and O-Bee Manfred Justice) have been 
genotyped 6 times. Assuming a cost of €160 
per genotype (including procurement of semen 
and DNA extraction) this amounts to a 
squandering of over €111,000 or US$138,000. 
However, this analysis does not include the 
genotypes of EuroGenomics which are likely 
to have considerable overlap. Therefore the 
squandering of funds of all genotypes analysis 
is likely to be at least double.  
Smaller breeds: Cooperation in genomic 
evaluation to achieve high accuracy of 
selection is likely to be greatest in smaller 
breeds because their global population will be 
considerably bigger than the respective 
populations in each individual country. This is 
the rationale behind the highly successful 
Intergenomics project for the Brown Swiss 
breed (Jorjani et al., 2010).  
Algorithms and software. Algorithms used in 
genomic selection differ among countries but 
details on those used are, in general, in the 
public domain. Irrespective, access to the best 
algorithms for genomic evaluation are key for 
each country to ensure that the GEBVs 
entering any international genomic evaluation 
are of the highest quality and rigorously tested. 
Some software for undertaking genomic 
selection is on the Clubware website 
(http://www.genomicselection.net).  
 
Traits difficult or expensive to measure. One 
advantage of collaboration in genomics often 
ignored is the ability to generate large 
populations for traits difficult or expensive to 
measure, such as animal health, product quality 
and greenhouse gas emissions. Surely dairy 
cattle breeders have learnt from past 
experiences where aggressive selection for a 
particular breeding goal had serious 
repercussions for other traits that were not 
measured at that time. The impact of such 
actions cost the dairy industry untold amounts 
and its effects are still being felt internationally. 
Pooling of resources across countries to 
measure such traits will lessen the possibility 
of reducing genetic merit for traits known to 
affect profitability, but not yet measured in 
sufficient numbers. The increase in accuracy of 
selection through genomic selection will 
indeed result in faster genetic gain for the traits 
under selection, but may also result in faster 
deterioration in traits not routinely measured. 
How this could work may be illustrated using 
the example of Bovine Tuberculosis (TB). 
Research in Ireland has shown that Bovine TB 
is heritable (Bermingham et al., 2009) and 
breeding values have been estimated for TB 
susceptibility. Several hundred Holstein-
Friesian sires with breeding values for TB have 
been genotyped with the Illumina Bovine50 
Beadchip. Knowledge of the selection intensity 
placed on each SNP in international breeding 
goals can be used to estimate the expected 
response to selection in genetic merit for 
susceptibility to TB.  
 
In theory, phenotypic files could also be 
made available to other participating countries 
in the future, to enable those countries start 
selecting for traits of interest. This would 
require the country to make some assumption 
regarding G*E interactions, but they would, at 
least, be in a position to start selecting for (or 
against) these important new traits. This is an 
example of where co-operation in genomics 
can and will move far beyond the routine 
sharing of genotypes, which is the focus of 
current discussions. 
Higher density chip and/or the sequencing of 
selected animals. Going forward, decisions 
will have to be made regarding the re-
genotyping of animals on a higher density chip 
and/or the sequencing of selected animals. 
Clearly having visibility of all animals in one 
common file would be advantageous for this 
process. Who pays for these ongoing costs is a 
relevant point that must be considered; 
individual countries that are prepared to share, 
co-operation through bi-lateral agreements, or 
is a more defined multi-country system 
required?  





Why is the collaboration not happening? 
 
There are also many reasons why genomic 
cooperation should not be pursued. Arguably 
the main reason relates to investment. Some 
companies/countries have made considerable 
investments in the genotyping of animals and 
acquirement of resources to undertake accurate 
genomic evaluations. Obviously these 
countries require a return on investment. This 
can be achieved through having (almost) 
exclusive access to the most accurate 
international genomic evaluations. By simply 
making a “pot” of genotypes other 
organisations can access these resources 
without any prior investment. However, these 
genotypes will be used by the “smaller” 
countries to generate the most accurate 
genomic evaluation for their respective 
countries, although this will also include a 
greater accuracy of selection for local bulls and 
dams which will subsequently compete with 
the importing market. Nevertheless, the most 
accurate genomic evaluations possible in 
importing countries can only be beneficial for 
the large exporting countries. 
 
 
How will we collaborate? 
 
There are many different options for 
collaboration including: 1) sharing of all 
genotypes and expertise amongst everyone, 2) 
sharing of genotypes and expertise among 
members of a consortium with or without 
similar resource input into the initiative, 3) 
swapping of genotypes in bilateral agreements, 
4) swapping of information on genotyped 
animals and animals where DNA or biological 
material is available. The latter three types of 
collaboration are already underway. Several 
consortia have been developed to share both 
genotypic information and skills in genomic 
evaluations. These include the North American 
consortium, EuroGenomics, and Intergenomics. 
In February 2010 the North American 
consortium had access to 37,409 genotypes on 
Holstein males and females of which 8,991 
were of proven Holstein bulls (Muir et al., 
2010). In March 2010, EuroGenomics had over 
16,000 Holstein bulls in their reference 
population (David et al., 2010).  
 
Also, bilateral agreements on swapping of 
genotypes or semen samples have been 
undertaken by many pairs of countries 
including Ireland, Poland, Italy, Switzerland, 
New Zealand and the UK. More importantly, 
the list of animals genotyped will be extremely 
helpful to those countries that have not yet 
genotyped (e.g., Spain, the UK, Belgium, 
South Africa) as they decide which bulls to 
genotype to maximise their training population 
through swapping. It is also useful information 
for all countries when deciding on which bulls 
to genotype in the future. Funding is always 
tight so the simple availability of such 
information is key to obtaining the best return 
on investment. The list of genotyped animals, 
and partnerships built, will also be useful in 
deciding which bulls should be 
genotyped/sequenced at greater densities.  
 
Arguably the best method to maximise the 
achievable accuracy of genomic evaluation in 
all countries is to openly share all genotypes. 
One such proposition has been called IGenoP 
(International Genomic Evaluation 
Partnership). 
IGenoP. Arising from the creation of the list of 
genotyped animals and various bi-lateral 
swapping agreements, it was obvious that 
some countries favoured an approach of more 
open collaboration. The motivation for IGenoP 
is therefore to facilitate national cattle animal 
evaluation units in the provision of genomic 
evaluations on their national base and scale 
using freely available genotypes. The initiative 
is open to all national cattle animal evaluation 
units that are members of Interbull.  
 
Although the IGenoP concept is still in the 
development phase, a number of important 
principles have been identified by the 
partnering countries. These include: 
 
• Open sharing of knowledge, tools and 
expertise. 
• That GEBVs should be made available 
to all breeders availing of the service. 
• Bull genotypes would be hosted at the 
Interbull Centre. 
• Each partner contributes all owned 
genotypes to the pool. 





• Partners can use the genotypes in the 
shared pool for all relevant research, 
development and implementation. 
• A sharing of knowledge regarding 
software development, e.g., Clubware. 
• Partners will not provide genotypes to 
third parties. 
• A definite commitment to only publish 
GEBVs on their country’s base and 
scale. 
To-date 12 countries have expressed 
interest in becoming involved in the IGenoP 
initiative. These are; Ireland, UK, Poland, Italy, 
South Africa, Spain, Japan, Switzerland, Israel, 
Belgium, New Zealand and Australia – all of 
which are listed as co-authors in this paper. 
Collectively these countries represent some 
13,285 bulls with genotypes, of which 11,801 
have MACE evaluations (another 6,871 proven 
bulls are due to be genotyped by these 
countries in the coming months). Other 
countries that are interested in becoming 
involved in the IGenoP initiative should make 
contact with any of the authors from this paper. 
 
Although still at an early stage, some issues 
have been identified by the partnering 
countries for further discussion. For example, 
will all participants be able to undertake 
required genomic evaluations for their 
respective country? If not, what are their 
options? What about sharing of phenotypes 
and is the sharing of software necessary? Also, 
should there be some minimum contribution of 
genotypes by a participating country to ensure 
participation? Clearly these are all issues that 
merit discussion. 
 
Some people have also asked as to whether 
IGenoP is a “competitor” to other initiatives 
that involve the sharing of genotypes. The 
simple answer is No. Instead, IGenoP should 
be viewed as simply another step in the process 
of ensuring greater international genomic co-
operation and hence more accurate genetic 
evaluations for participating countries.  
 
Avoiding duplication is a strong 
motivational desire within the current partners. 
Whilst this relates to the cost of genotyping, it 
also relates to co-operation agreements 
between the various countries (i.e., bi and 
multi-lateral sharing arrangements), all of 
which take up time, effort and money. It is for 
these reasons that the IGenoP partners are 
committed to seeing these functions (i.e., lists, 
genotypes and phenotypes) placed within the 
Interbull centre and within the various steering 
and technical groups, of which we are 
participating members. By doing so, each 
country is making best use of its national 
resources, whilst also remaining committed to 
its overall objective of providing the most 
accurate genetic evaluations for the country 





There is no denying the benefits in accuracy of 
selection achievable through collaboration. 
Several types of collaboration in genomics are 
currently underway among different bodies 
each requiring their own resource input from 
already strained national genetic evaluation 
bodies. There is an opportunity now to develop 
a streamline international genomic evaluation 
process to maximise the gain achievable by all, 
for the benefit of all. Finally, advancements in 
both the methodology of genomic selection but 
more importantly the perspective of genomic 
selection and collaboration has changed. 
Therefore, it might be worthwhile re-
evaluating through another Interbull survey, 
individual countries’ thoughts on genomic 
selection and international collaboration. This 
is especially prudent as we move towards the 






Bermingham, M.L., More, S.J., Good, M., 
Cromie, A.R., Higgins, I.M., Brotherstone, 
S. & Berry, D.P. 2009. Genetics of 
tuberculosis in Irish Holstein-Friesian dairy 
herds. J. Dairy Sci. 92, 3447-3456. 
Coffey, M. & Mrode, R. 2009. Clubware – A 
collaborative genomic breeding value 
estimation software development platform. 
Interbull Bulletin 39, 73-76. UPPSALA, 
SWEDEN. January 26-29, 2009. 
David, X., de Vries, A., Feddersen, E. & 
Borchersen,  S. 2010. International genomic 
cooperation - European perspective. 





Interbull Bulletin 41. Paris, France. 
March 4-5, 2010. 
Jorjani, H., Zumbach, B., Dürr, J. & Santus, E. 
2010. Joint genomic evaluation of BSW 
populations. Interbull Bulletin 41. Paris, 
France. March 4-5, 2010. 
Muir, B., Van Doormaal, B. & Kistemaker, G. 
2010. International genomic cooperation – 
North American perspective. Interbull 
Bulletin 41. Paris, France. March 4-5, 2010. 
Schrooten, C. & van der Linde, C. 2010. 
Multi-country genomic selection. Interbull 










































Sullivan, P.G. & VanRaden, P.M. 2009. 
Development of Genomic MACE. Interbull 
Bulletin 40, 157-161. Barcelona, Spain, 
August 21-24, 2009. 
Sullivan, P.G. & VanRaden, P.M. 2010. 
GMACE implementation. Interbull Bulletin 
41. Paris, France. March 4-5, 2010. 
VanRaden, P.M., Wiggans, G.R., Van Tassell, 
C.P., Sonstegard, T.S. & Schenkel, F. 2009. 
Benefits from Cooperation in genomics. 
Interbull Bulletin 39, 67-72. UPPSALA, 
SWEDEN. January 26-29, 2009. 
